{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:55:44Z","timestamp":1781528144952,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107106","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:51:33Z","timestamp":1772347893000},"page":"107106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3202-6921","authenticated-orcid":false,"given":"Alexandra","family":"Balshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursela","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.msard.2026.107106_bib0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1177\/13524585251342725","article-title":"Malignant melanoma and multiple sclerosis therapies: a disproportionality analysis of the FDA adverse event reporting system","volume":"31","author":"Balshi","year":"2025","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2026.107106_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00415-025-12980-x","article-title":"A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies","volume":"272","author":"Balshi","year":"2025","journal-title":"J. Neurol."},{"issue":"10000","key":"10.1016\/j.msard.2026.107106_bib0002","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(15)00275-5","article-title":"Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management","volume":"386","author":"Bhangu","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.msard.2026.107106_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157753","article-title":"OpenVigil FDA - inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications","volume":"11","author":"B\u00f6hm","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.msard.2026.107106_bib0007","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug. Saf."},{"issue":"6","key":"10.1016\/j.msard.2026.107106_bib0008","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The REporting of A disproportionality analysis for DrUg safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.msard.2026.107106_bib0012","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1212\/NXI.0000000000000517","article-title":"Disease-modifying therapies alter gut microbial composition in MS","volume":"6","author":"Katz Sand","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.msard.2026.107106_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14326","article-title":"Gastrointestinal motility disorders in patients with multiple sclerosis: a single-center study","volume":"34","author":"Khanna","year":"2022","journal-title":"Neurogastroenterol. Motil."},{"issue":"5","key":"10.1016\/j.msard.2026.107106_bib0003","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/13524585251316518","article-title":"Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: a fumaric acid ester class new safety risk","volume":"31","author":"Kim","year":"2025","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107106_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/13524585251382397","article-title":"Anaphylaxis and glatiramer acetate","author":"Kim","year":"2025","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2026.107106_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12821","article-title":"Te Velde AA. The immunology of the vermiform appendix: a review of the literature","volume":"186","author":"Kooij","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2026.107106_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200164","article-title":"Multiple sclerosis, disease-modifying therapies, and infections","volume":"10","author":"Langer-Gould","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.msard.2026.107106_bib0011","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3\u20134","key":"10.1016\/j.msard.2026.107106_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0171-2985(00)80098-4","article-title":"Phenotypic pattern of B cells in the appendix: reduced intensity of CD19 expression","volume":"201","author":"Somekh","year":"2000","journal-title":"Immunobiology"},{"key":"10.1016\/j.msard.2026.107106_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1249201","article-title":"Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control","volume":"14","author":"von Essen","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:24:16Z","timestamp":1781526256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":15,"alternative-id":["S2211034826001422"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107106","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107106"}}